Marpai, Inc. (MRAI)
Pre-Market:
| Previous Close | 2.1250 |
| Open | 2.1000 |
| Bid | 2.1000 x 100 |
| Ask | 2.2100 x 100 |
| Day's Range | 2.0900 - 2.2400 |
| 52 Week Range | 0.3300 - 3.4600 |
| Volume | |
| Avg. Volume | 432,177 |
| Market Cap | 22.043M |
| Beta (5Y Monthly) | 5.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.1400 |
| Earnings Date | May 10, 2024 - May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.00 |
PR NewswireMARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVES
Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced the strategic hiring of two industry-renowned salespeople, significantly strengthening its sales force with a focus on accelerating its growth trajectory. These appointments underscore Marpai's commitment to accelerating growth and exp
- PR Newswire
MARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTES
Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced the sale of new three-year, $11.83 million convertible notes to funds managed by JGB Management Inc.
Insider MonkeyMarpai, Inc. (NASDAQ:MRAI) Q4 2023 Earnings Call Transcript
Marpai, Inc. (NASDAQ:MRAI) Q4 2023 Earnings Call Transcript March 27, 2024 Marpai, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the Marpai Fourth Quarter and Fiscal Year 2023 Earnings Conference Call. All participants will […]
